Medical Properties Trust, Inc. (NYSE:MPW - Get Free Report) has earned a consensus recommendation of "Hold" from the seven brokerages that are currently covering the firm, Marketbeat reports. Six research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $4.92.
A number of research firms recently weighed in on MPW. Truist Financial lowered their price target on Medical Properties Trust from $6.00 to $4.00 and set a "hold" rating on the stock in a report on Thursday, December 19th. Mizuho dropped their price target on Medical Properties Trust from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Thursday, December 5th.
Check Out Our Latest Stock Report on MPW
Medical Properties Trust Price Performance
MPW traded up $0.32 on Monday, hitting $5.90. 37,733,618 shares of the company were exchanged, compared to its average volume of 13,131,109. Medical Properties Trust has a fifty-two week low of $3.51 and a fifty-two week high of $6.55. The company has a debt-to-equity ratio of 1.69, a quick ratio of 2.38 and a current ratio of 2.38. The firm has a market capitalization of $3.54 billion, a P/E ratio of -1.40, a price-to-earnings-growth ratio of 1.01 and a beta of 1.32. The business's fifty day moving average is $4.44 and its 200 day moving average is $4.66.
Medical Properties Trust Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 10th will be paid a dividend of $0.08 per share. This represents a $0.32 dividend on an annualized basis and a dividend yield of 5.43%. The ex-dividend date of this dividend is Monday, March 10th. Medical Properties Trust's payout ratio is currently -7.58%.
Insider Buying and Selling
In other Medical Properties Trust news, CAO James Kevin Hanna sold 11,641 shares of the firm's stock in a transaction dated Thursday, December 26th. The shares were sold at an average price of $3.72, for a total transaction of $43,304.52. Following the sale, the chief accounting officer now directly owns 366,913 shares of the company's stock, valued at $1,364,916.36. This trade represents a 3.08 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.53% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in MPW. Allworth Financial LP raised its stake in Medical Properties Trust by 230.4% during the fourth quarter. Allworth Financial LP now owns 6,082 shares of the real estate investment trust's stock worth $26,000 after purchasing an additional 4,241 shares during the period. Truvestments Capital LLC acquired a new stake in Medical Properties Trust during the third quarter valued at approximately $31,000. RFG Advisory LLC acquired a new position in shares of Medical Properties Trust in the 4th quarter valued at about $40,000. Silver Oak Securities Incorporated bought a new position in Medical Properties Trust during the 4th quarter worth $40,000. Finally, Verus Capital Partners LLC bought a new stake in shares of Medical Properties Trust during the fourth quarter valued at approximately $40,000. Hedge funds and other institutional investors own 71.79% of the company's stock.
About Medical Properties Trust
(
Get Free ReportMedical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
See Also

Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.